ACAD (acadia-pharm.com) Prakiraan pendapatan perusahaan
Effective distribution channels for ACADIA Pharmaceuticals (ACAD) neuro-drugs provide excellent operating leverage. The future sales volume vector on the GURU.Markets daily chart shows that the current status is 0.61. However, revenues are based on a narrow portfolio of FDA-supervised drugs, and global political fragmentation complicates the international logistics of components and the conduct of global clinical trials.
Rincian metrik keuangan lan pasar ACADIA Corp (ACAD)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas ACADIA Pharmaceuticals|ACAD - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas acadia-pharm.com|ACAD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ACADIA Pharmaceuticals Inc|ACAD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ACADIA Pharmaceuticals|Rasio cepet acadia-pharm.com
- statistik bathi lan rasio pasar:
ACAD - Penghasilan resik perusahaan|Bathi mangsa ngarep ACADIA Pharmaceuticals|ACAD - Pangali P/E|Prakiraan rega marang bathi ACADIA Pharmaceuticals Inc.|ACAD - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA ACADIA Pharmaceuticals Inc.|ACAD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) ACADIA Pharmaceuticals|ACAD - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan acadia-pharm.com|ACAD - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ACADIA Pharmaceuticals
- informasi babagan volume dodolan lan pendapatan:
Analisis fundamental perusahaan:acadia-pharm.com
To objectively measure the operational success of ACADIA Pharmaceuticals (ACAD), investors must track real market demand trends that lead quarterly financial reports. The company's projected sales metric mathematically eliminates the time lag, reflecting the expansion potential of Daybue and the stability of Nuplazid, which allows this chart to assess the asset's fundamental value without the influence of market noise or emotional volatility.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|Xenon Corp - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Prakiraan pendapatan perusahaan Denali Therapeutics Inc|Volume dodolan sing dikarepake perusahaan Harmony Corp HRMY|Prakiraan volume dodolan BHVN|Volume dodolan mangsa ngarep perusahaan Amylyx Pharmaceuticals AMLX|Prakiraan volume dodolan TRVI (Trevi Corp)|Dodolan mangsa ngarep perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Prakiraan volume dodolan|CeriBell Corp (CBLL) - Volume dodolan mangsa ngarep perusahaan|Prothena Corp (PRTA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alector Inc. (ALEC)|Volume dodolan mangsa ngarep perusahaan ANNX|omeros.com (OMER) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VYGR (voyagertherapeutics.com)|Dodolan mangsa ngarep perusahaan Neumora Therapeutics (NMRA)|SCLX - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Prakiraan pendapatan perusahaan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (inhibikase.com) - Prakiraan volume dodolan|cassavasciences.com (SAVA) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan ASRT (Assertio Therapeutics)|Dodolan mangsa ngarep perusahaan Coya Therapeutics|Vistagen - Volume dodolan mangsa ngarep perusahaan|ovidrx.com (OVID) - Volume dodolan sing dikarepake perusahaan|Acumen Pharmaceuticals - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan cervomed.com|ATHE: Prakiraan volume dodolan|Clene Inc - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics
